These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 28518219)

  • 1. Impact of the timing of hepatitis B virus identification and anti-hepatitis B virus therapy initiation on the risk of adverse liver outcomes for patients receiving cancer therapy.
    Hwang JP; Suarez-Almazor ME; Cantor SB; Barbo A; Lin HY; Ahmed S; Chavez-MacGregor M; Donato-Santana C; Eng C; Ferrajoli A; Fisch MJ; McLaughlin P; Simon GR; Rondon G; Shpall EJ; Lok AS
    Cancer; 2017 Sep; 123(17):3367-3376. PubMed ID: 28518219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of hepatitis B virus screening and antiviral prophylaxis with adverse liver outcomes in Chinese cancer patients undergoing chemotherapy: A retrospective study.
    He LY; Wang YL; Tian X; Chen WQ
    Medicine (Baltimore); 2020 Apr; 99(14):e19647. PubMed ID: 32243396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
    Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
    World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience.
    Papadopoulos N; Deutsch M; Manolakopoulos S; Bitsi C; Michalakeas H; Poulakidas H; Tsironi E; Giannouli S; Papatheodoridis GV; Koskinas J; Pectasides D
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):56-60. PubMed ID: 27669175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
    Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
    World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
    Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
    Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis.
    Paul S; Dickstein A; Saxena A; Terrin N; Viveiros K; Balk EM; Wong JB
    Hepatology; 2017 Aug; 66(2):379-388. PubMed ID: 28128861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvements in hepatitis B virus screening before rituximab therapy: A community-based, safety-net hospital experience.
    Junus K; Aguilar M; Patel P; Irwin D; Yee S; Liu B; Bhuket T; Wong RJ
    Cancer; 2017 Feb; 123(4):650-656. PubMed ID: 27696389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation during anti-cancer chemotherapy in patients with past hepatitis B virus infection.
    Kim E; Yune S; Ha JM; Lee WJ; Hwang JW; Paik YH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Hepatogastroenterology; 2014 Sep; 61(134):1704-11. PubMed ID: 25436366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive outcomes of on- and off-antiviral prophylaxis in hepatitis B patients undergoing cancer chemotherapy: A competing risks analysis.
    An J; Shim JH; Kim SO; Choi J; Kim SW; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Med Virol; 2016 Sep; 88(9):1576-86. PubMed ID: 26945543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the risk of hepatitis B reactivation in patients with haematological malignancies: is the serum hepatitis B virus profile reliable?
    Ferraro D; Pizzillo P; Di Marco V; Vultaggio A; Iannitto E; Venezia G; Craxì A; Di Stefano R
    Liver Int; 2009 Sep; 29(8):1171-7. PubMed ID: 19602139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus screening and reactivation and management of patients with nasopharyngeal carcinoma: A large-scale, big-data intelligence platform-based analysis from an endemic area.
    Lv JW; Chen YP; Huang XD; Zhou GQ; Chen L; Li WF; Tang LL; Mao YP; Guo Y; Xu RH; Ma J; Sun Y
    Cancer; 2017 Sep; 123(18):3540-3549. PubMed ID: 28493307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.
    Chen CY; Tien FM; Cheng A; Huang SY; Chou WC; Yao M; Tang JL; Tien HF; Sheng WH
    BMC Gastroenterol; 2018 Jan; 18(1):6. PubMed ID: 29310589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute exacerbation of chronic hepatitis B infection in cancer patients receiving chemotherapy in a hepatitis B virus endemic area.
    Hsu PI; Lai KH; Cheng JS; Kao SS; Li YR; Sun WC; Chen WC; Lin KH; Shin CA; Chiang PH; Li YD; Ou WT; Chen HC; Yu HC
    Hepatology; 2015 Aug; 62(2):387-96. PubMed ID: 26041578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.
    Shih CA; Chen WC; Yu HC; Cheng JS; Lai KH; Hsu JT; Chen HC; Hsu PI
    PLoS One; 2015; 10(8):e0132426. PubMed ID: 26274393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies.
    Kawatani T; Suou T; Tajima F; Ishiga K; Omura H; Endo A; Ohmura H; Ikuta Y; Idobe Y; Kawasaki H
    Eur J Haematol; 2001 Jul; 67(1):45-50. PubMed ID: 11553266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of hepatitis B virus reactivation in patients with hematological malignancies treated with chemotherapy.
    Francisci D; Falcinelli F; Schiaroli E; Capponi M; Belfiori B; Flenghi L; Baldelli F
    Infection; 2010 Feb; 38(1):58-61. PubMed ID: 19904491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network.
    Kwak YE; Stein SM; Lim JK
    Dig Dis Sci; 2018 Jan; 63(1):61-71. PubMed ID: 29177849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.